Literature DB >> 22718833

The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.

Christina Raupp1, Matthias Naumer, Oliver J Müller, Brittney L Gurda, Mavis Agbandje-McKenna, Jürgen A Kleinschmidt.   

Abstract

Adeno-associated virus (AAV) has attracted considerable interest as a vector for gene therapy owing its lack of pathogenicity and the wealth of available serotypes with distinct tissue tropisms. One of the most promising isolates for vector development, based on its superior gene transfer efficiency to the liver in small animals compared to AAV type 2 (AAV2), is AAV8. Comparison of the in vivo gene transduction of rAAV2 and rAAV8 in mice showed that single amino acid exchanges in the 3-fold protrusions of AAV8 in the surface loops comprised of residues 581 to 584 and 589 to 592 to the corresponding amino acids of AAV2 and vice versa had a strong influence on transduction efficiency and tissue tropism. Surprisingly, not only did conversion of AAV8 to AAV2 cap sequences increase the transduction efficiency and change tissue tropism but so did the reciprocal conversion of AAV2 to AAV8. Insertion of new peptide motifs at position 590 in AAV8 also enabled retargeting of AAV8 capsids to specific tissues, suggesting that these sequences can interact with receptors on the cell surface. However, a neutralizing monoclonal antibody that binds to amino acids (588)QQNTA(592) of AAV8 does not prevent cell binding and virus uptake, indicating that this region is not necessary for receptor binding but rather that the antibody interferes with an essential step of postattachment processing in which the 3-fold protrusion is also involved. This study supports a multifunctional role of the 3-fold region of AAV capsids in the infection process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718833      PMCID: PMC3416165          DOI: 10.1128/JVI.00209-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  91 in total

Review 1.  Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.

Authors:  Nicholas Muzyczka; Kenneth H Warrington
Journal:  Hum Gene Ther       Date:  2005-04       Impact factor: 5.695

Review 2.  New recombinant serotypes of AAV vectors.

Authors:  Guangping Gao; Luk H Vandenberghe; James M Wilson
Journal:  Curr Gene Ther       Date:  2005-06       Impact factor: 4.391

3.  AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.

Authors:  Christine M Barbon; Robin J Ziegler; Chester Li; Donna Armentano; Maribeth Cherry; Robert J Desnick; Edward H Schuchman; Seng H Cheng
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

4.  Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.

Authors:  Hiroyuki Nakai; Xiaolin Wu; Sally Fuess; Theresa A Storm; David Munroe; Eugenio Montini; Shawn M Burgess; Markus Grompe; Mark A Kay
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart.

Authors:  Zhong Wang; Tong Zhu; Chunping Qiao; Liqiao Zhou; Bing Wang; Jian Zhang; Chunlian Chen; Juan Li; Xiao Xiao
Journal:  Nat Biotechnol       Date:  2005-02-27       Impact factor: 54.908

Review 6.  Adeno-associated viral vectors for clinical gene transfer studies.

Authors:  Richard O Snyder; Joyce Francis
Journal:  Curr Gene Ther       Date:  2005-06       Impact factor: 4.391

Review 7.  AAV hybrid serotypes: improved vectors for gene delivery.

Authors:  Vivian W Choi; Douglas M McCarty; R Jude Samulski
Journal:  Curr Gene Ther       Date:  2005-06       Impact factor: 4.391

8.  Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.

Authors:  Baodong Sun; Haoyue Zhang; Luis M Franco; Sarah P Young; Ayn Schneider; Andrew Bird; Andrea Amalfitano; Y-T Chen; Dwight D Koeberl
Journal:  Mol Ther       Date:  2005-01       Impact factor: 11.454

9.  Gene transfer into skeletal muscle using novel AAV serotypes.

Authors:  Jean-Pierre Louboutin; Lili Wang; James M Wilson
Journal:  J Gene Med       Date:  2005-04       Impact factor: 4.565

10.  Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.

Authors:  L Denby; S A Nicklin; A H Baker
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

View more
  27 in total

Review 1.  E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.

Authors:  Dirk Grimm; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

2.  Structural insights into adeno-associated virus serotype 5.

Authors:  Lakshmanan Govindasamy; Michael A DiMattia; Brittney L Gurda; Sujata Halder; Robert McKenna; John A Chiorini; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

3.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

4.  Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening.

Authors:  Kathleen Börner; Eike Kienle; Lin-Ya Huang; Jonas Weinmann; Anna Sacher; Philipp Bayer; Christian Stüllein; Julia Fakhiri; Laura Zimmermann; Adrian Westhaus; Jürgen Beneke; Nina Beil; Ellen Wiedtke; Carolin Schmelas; Dominik Miltner; Alexander Rau; Holger Erfle; Hans-Georg Kräusslich; Martin Müller; Mavis Agbandje-McKenna; Dirk Grimm
Journal:  Mol Ther       Date:  2020-02-13       Impact factor: 11.454

5.  Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.

Authors:  Yu-Shan Tseng; Brittney L Gurda; Paul Chipman; Robert McKenna; Sandra Afione; John A Chiorini; Nicholas Muzyczka; Norman H Olson; Timothy S Baker; Jürgen Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

6.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

Review 7.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

8.  Comparative analysis of adeno-associated virus capsid stability and dynamics.

Authors:  Vamseedhar Rayaprolu; Shannon Kruse; Ravi Kant; Balasubramanian Venkatakrishnan; Navid Movahed; Dewey Brooke; Bridget Lins; Antonette Bennett; Timothy Potter; Robert McKenna; Mavis Agbandje-McKenna; Brian Bothner
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

9.  Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function.

Authors:  April R Giles; Joshua J Sims; Kevin B Turner; Lakshmanan Govindasamy; Mauricio R Alvira; Martin Lock; James M Wilson
Journal:  Mol Ther       Date:  2018-10-18       Impact factor: 11.454

10.  Adeno-associated virus structural biology as a tool in vector development.

Authors:  Lauren M Drouin; Mavis Agbandje-McKenna
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.